Ambicare Health Limited

Ambicare Health Limited

Wearable LED phototherapy devices for dermatological conditions.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
*

£495k

Early VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2010201120122013201420152018
Revenues0000000000000000000000000000
% growth-(72 %)11746 %(29 %)(6 %)(53 %)-
EBITDA0000000000000000000000000000
% EBITDA margin(6956 %)(50965 %)(426 %)(432 %)(357 %)(424 %)-
Profit0000000000000000000000000000
% profit margin(6451 %)(46775 %)(416 %)(438 %)(368 %)(403 %)-
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Notes (0)
More about Ambicare Health Limited
Made with AI
Edit

Ambicare Health Limited operates as a designer, developer, and distributor of medical-grade LED phototherapy devices for skincare. The company was established in 2004 as a spin-out from the University of St Andrews, NHS Tayside, and Scottish Health Innovations Ltd. . The scientific foundation of the company stems from the pioneering work of its founders, Professor Ifor Samuel and Professor James Ferguson. . Professor Samuel, holding a PhD in Physics from Cambridge, is the founder of the Organic Semiconductor Centre at the University of St Andrews, focusing on organic semiconductors and their applications in medicine. . Professor Ferguson is a consultant dermatologist from Ninewells Hospital, recognized for his significant contributions to photodermatology and the establishment of the photobiology unit at the hospital. .

The firm's business model encompasses both direct-to-consumer sales under its proprietary brand, LUSTRE® Skin, and private label services for other brands. Its initial product, Ambulight, was a hospital-based LED therapy for treating non-melanoma skin cancer. . Leveraging this core technology, the company expanded into the consumer market, targeting common dermatological concerns such as acne and signs of aging. . Revenue is generated through the sale of these devices and related skincare products. The product portfolio includes a range of wearable light therapy devices designed for at-home use. . A key patented feature allows users to wear the device, ensuring consistent and convenient light delivery to the skin. .

The LUSTRE® ClearSkin product line, which includes devices like the SOLO, TRIO, and full-face masks, utilizes different wavelengths of light to address specific skin issues. . Blue light is used to target acne-causing bacteria, while red and near-infrared light aim to reduce inflammation, stimulate collagen, and improve skin texture. . These products have obtained CE certification for sale in the European Economic Area and FDA clearance for over-the-counter sales in the US for treating mild-to-moderate acne. . The company also offers supplementary products, such as skin tablets, that work internally to address skin concerns. . Ambicare Health has secured significant investment funding and distributes its products globally through various channels, including its own website and major retailers like Boots. .

Keywords: LED phototherapy, dermatology, wearable medical devices, skincare technology, acne treatment, skin rejuvenation, anti-aging, photodynamic therapy, blue light therapy, red light therapy, private label skincare, St Andrews University spin-out, Ninewells Hospital, Ifor Samuel, James Ferguson, LUSTRE Skin, Ambulight, home-use medical devices, non-invasive treatment, CE certified, FDA cleared

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo